209 related articles for article (PubMed ID: 31024459)
1. High Thyroid Stimulating Hormone Level Is Associated With Hyperandrogenism in Euthyroid Polycystic Ovary Syndrome (PCOS) Women, Independent of Age, BMI, and Thyroid Autoimmunity: A Cross-Sectional Analysis.
Cai J; Zhang Y; Wang Y; Li S; Wang L; Zheng J; Jiang Y; Dong Y; Zhou H; Hu Y; Ma J; Liu W; Tao T
Front Endocrinol (Lausanne); 2019; 10():222. PubMed ID: 31024459
[No Abstract] [Full Text] [Related]
2. Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome?
Lee HJ; Jo HN; Noh HK; Kim SH; Joo JK
Ginekol Pol; 2022 Mar; ():. PubMed ID: 35315007
[TBL] [Abstract][Full Text] [Related]
3. Ovarian Reserve and Serum Concentration of Thyroid Peroxidase Antibodies in Euthyroid Women With Different Polycystic Ovary Syndrome Phenotypes.
Adamska A; Łebkowska A; Krentowska A; Hryniewicka J; Adamski M; Leśniewska M; Polak AM; Kowalska I
Front Endocrinol (Lausanne); 2020; 11():440. PubMed ID: 32849259
[No Abstract] [Full Text] [Related]
4. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
[TBL] [Abstract][Full Text] [Related]
5. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
6. Detection of thyroid autoimmunity markers in euthyroid women with polycystic ovary syndrome: a case-control study from syria.
Al-Saab R; Haddad S
Int J Endocrinol Metab; 2014 Jul; 12(3):e17954. PubMed ID: 25237328
[TBL] [Abstract][Full Text] [Related]
7. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
8. [Subclinical hypothyroidism and endocrine metabolic characteristics in women with polycystic ovary syndrome].
Yue F; Zhang D; Gong F; Zhang L; Sun Z; Lei M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 42(8):940-946. PubMed ID: 28872086
[TBL] [Abstract][Full Text] [Related]
9. The relationship between thyroid function and metabolic changes in Chinese women with polycystic ovary syndrome.
Yin D; Ruan X; Tian X; Du J; Zhao Y; Cui Y; Li Y; Mueck AO
Gynecol Endocrinol; 2017 Apr; 33(4):332-335. PubMed ID: 28051891
[TBL] [Abstract][Full Text] [Related]
10. [THYROID STIMULATING HORMONE LEVELS IN EUTHYROID WOMEN WITH POLYCYSTIC OVARY SYNDROME].
Mitkov M; Nyagolova P; Orbetzova M
Akush Ginekol (Sofiia); 2015; 54(6):10-5. PubMed ID: 26817257
[TBL] [Abstract][Full Text] [Related]
11. [Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome].
Hu WH; Qiao J; Zhao SY; Zhang XW; Li MZ
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):487-91. PubMed ID: 17068620
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of Hashimoto's thyroiditis in patients with polycystic ovary syndrome: does the imbalance between estradiol and progesterone play a role?
Arduc A; Aycicek Dogan B; Bilmez S; Imga Nasiroglu N; Tuna MM; Isik S; Berker D; Guler S
Endocr Res; 2015; 40(4):204-10. PubMed ID: 25822940
[TBL] [Abstract][Full Text] [Related]
13. Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6.
Siemińska L; Wojciechowska C; Walczak K; Borowski A; Marek B; Nowak M; Kajdaniuk D; Foltyn W; Kos-Kudła B
Endokrynol Pol; 2015; 66(5):394-403. PubMed ID: 26457493
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
[TBL] [Abstract][Full Text] [Related]
15. Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes.
Mumm H; Jensen DM; Sørensen JA; Andersen LL; Ravn P; Andersen M; Glintborg D
Acta Obstet Gynecol Scand; 2015 Feb; 94(2):204-11. PubMed ID: 25417943
[TBL] [Abstract][Full Text] [Related]
16. Subclinical hypothyroidism in patients with polycystic ovary syndrome: distribution and its association with lipid profiles.
Huang R; Zheng J; Li S; Tao T; Liu W
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():52-6. PubMed ID: 24768234
[TBL] [Abstract][Full Text] [Related]
17. Association between lipids profile and thyroid parameters in euthyroid diabetic subjects: a cross-sectional study.
Zhang Y; Lu P; Zhang L; Xiao X
BMC Endocr Disord; 2015 Mar; 15():12. PubMed ID: 25887732
[TBL] [Abstract][Full Text] [Related]
18. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
19. Impact of elevated thyroid-stimulating hormone levels in polycystic ovary syndrome.
Trummer C; Schwetz V; Giuliani A; Obermayer-Pietsch B; Lerchbaum E
Gynecol Endocrinol; 2015 Oct; 31(10):819-23. PubMed ID: 26190535
[TBL] [Abstract][Full Text] [Related]
20. Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome.
Mueller A; Schöfl C; Dittrich R; Cupisti S; Oppelt PG; Schild RL; Beckmann MW; Häberle L
Hum Reprod; 2009 Nov; 24(11):2924-30. PubMed ID: 19654109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
